Answers are grounded in this paper and cite their sources.
Ovarian aging is an early feature of human aging with broad consequences for women's health, yet its cellular dynamics across the menopausal transition remain unclear. We integrated single-cell transcriptomic, chromatin accessibility and spatial transcriptomic profiles across young, menopausal-transition and postmenopausal human ovaries. Granulosa cells (GCs) exhibited the most pronounced age-associated transcriptional remodelling. The menopausal transition was characterized by reduced DNA-repair activity and elevated stress-response programs in GCs, alongside broader changes in hormone-response and steroid-metabolic programs during ovarian aging. Integrated regulatory analyses implicated HEYL, a GC-enriched transcription factor, with reduced accessibility at a putative regulatory element during aging. Genetic analyses associated HEYL and its predicted upstream regulators with age at natural menopause, while spatial mapping revealed enrichment of menopause-associated genetic signals in GC-rich regions. HEYL depletion increased senescence-associated phenotypes in human granulosa-like cells and primary mouse GCs, whereas overexpression attenuated oxidative-stress-induced senescence. Perturbation of its orthologue Hey produced consistent effects in Drosophila ovaries. Together, our atlas reveals stage-associated granulosa-cell remodeling and implicates HEYL in ovarian aging.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: